Drug prices are still rising, with manufacturers hiking up prices at the start of 2020. And the “reluctance” from the Republican party to challenge those rising prices could become a huge liability for the upcoming 2020 election, according to The Hill.

That’s because the Trump administration made lowering drug prices a huge cornerstone of its healthcare agenda, releasing a blueprint early on in the administration’s control and proposing several modest policies that could lower the cost of some prescription drugs under Medicare. However, critics have pointed out that another recent proposal to import some drugs from Canada at lower prices might not actually work.

In addition, Republicans are staunchly against legislation that would actually limit what drugmakers are allowed to charge for drugs––something other countries actively do to keep costs in check. Further, Senate Majority Leader Mitch McConnell (R-KY) refuses to hold votes for several bipartisan bills that would impact drug prices.

“But as Republicans fight to keep control of the Senate, doing nothing on an issue of vast importance to voters is also a gamble,” the report from The Hill reads.

See the full story below: